ADIL Stock Analysis: Buy, Sell, or Hold?
ADIL - Adial Pharmaceuticals, Inc
$2.55
-0.16 (-5.90%)
▼
5d:
-10.53%
30d:
+10.87%
90d:
+38.59%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When ADIL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ADIL is down 10.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ADIL is down 10.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ADIL is currently trading at $2.55, which is considered slightly high relative to its 30-day fair value range of $2.01 to $2.72.
Technical Outlook: Technically, ADIL is showing sideways momentum. Immediate support is located at $2.11, while resistance sits at $5.17. Short-term momentum is weak, with the stock down 5.9% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.00 (+174.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ADIL is showing sideways momentum. Immediate support is located at $2.11, while resistance sits at $5.17. Short-term momentum is weak, with the stock down 5.9% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.00 (+174.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.01 -
$2.72
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.6%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.9%)
- BULLISH: Trading 174.5% below Wall St target ($7.00)
- WARNING: Recommendation downgraded due to -10.5% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$2.01 -
$2.72
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.11
Resistance Level
$5.17
Current Trend
Sideways
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.47
Wall Street Target
$7.00
(+174.5%)
Share & Embed Analysis
Last updated: June 23, 2026 8:05 PM ET
Data refreshes hourly during market hours. Next update: 9:05 PM
Data refreshes hourly during market hours. Next update: 9:05 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADIL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 67 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 67 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$105 | 64 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 65 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$257 | 59 HOLD |
